在翻译医学中克服可扩展iPSC生成的挑战
Ding-Hao Liu1,2, Huan-Chin Tseng3,4, Meng-Shiue Lee5
1Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
Journal of the Chinese Medical Association : JCMA
|December 22, 2023
概括
诱导多能干细胞 (iPSCs) 提供再生医学潜力,但面临着挑战. 这项研究确定了具有优势的HLA类型的"超级捐赠者"的iPSC细胞系,为改进疗法创造了标准化的细胞来源.
科学领域:
- 干细胞生物学 干细胞生物学
- 再生医学是一种再生医学.
- 免疫学 免疫学 免疫学
背景情况:
- 诱导多能干细胞 (iPSCs) 对再生医学具有重大前景,包括细胞替代和疾病建模.
- 在iPSC治疗中的挑战包括调节差异化和管理个体之间的遗传变异.
- 具有优势遗传特征的"超级捐赠者"概念为标准化,高质量的iPSC来源提供了解决方案.
研究的目的:
- 从具有特定人类白细胞抗原 (HLA) 类型的捐赠者中建立诱导多能干细胞 (iPSC) 线.
- 通过利用具有遗传优势的"超级捐赠者"来应对iPSC疗法的挑战.
主要方法:
- 选择了具有特定HLA类型 (A33:03-B58:01-DRB1*03:01) 的捐赠者.
- 从这些捐赠者中重新编程体细胞以产生诱导多能干细胞 (iPSC) 线.
- 对生成的 iPSC 线进行了广泛的表征.
主要成果:
- 从具有指定HLA类型的捐赠者成功生成了iPSC线.
- 生成的iPSC线条表现出了详细记录的独特特征.
- 这一成就代表了利用超级捐赠者的iPSCs在治疗应用中的重要一步.
结论:
- 从具有特定HLA类型的超级捐赠者建立iPSC线条是再生医学的关键进展.
- 这些标准化,高质量的细胞来源减轻了个体间的差异,提高了治疗疗效.
- 这些发现为未来的研究提供了基础,提高了基于iPSC的疗法的疗效和可访问性.
更多相关视频
09:34Automated Production of Human Induced Pluripotent Stem Cell-Derived Cortical and Dopaminergic Neurons with Integrated Live-Cell Monitoring
Published on: August 6, 2020
7.3K
05:38Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells
Published on: February 12, 2021
4.2K
相关概念视频
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
